Explore the vast range of titles available.

Purpose LGBTQ + college students experience interpersonal violence at disproportionately high rates, underscoring the need for college campuses to provide inclusive violence prevention and intervention services. We sought to examine similarities and differences in barriers to accessing campus-based services and recommendations for campus-based violence prevention and intervention service between LGBTQ + college students compared to cisgender heterosexual college students. Methods Open-ended responses to the question on an annual campus climate survey were analyzed from 273 victims of sexual or sexuality-based harassment, sexual violence, dating violence, or stalking. Data were coded using a content analysis approach, with each excerpt being coded by two trained researchers. Results Two major themes emerged: barriers to accessing campus-based resources and recommendations for campus-based resources. Subthemes within barriers included tacit barriers (including off-campus experiences not warranting on-campus responses and dismissal of violence experiences) and explicit barriers (including lack of knowledge about services, reputation of services, and gender). Recommendations for campus-based services included themes of content and outreach, who to train, and additional resources. Many themes were raised by both LGBTQ + students and cisgender heterosexual students, whereas others were unique to either subgroup. Conclusions Universities should consider these themes when developing prevention and intervention services. This includes engaging in awareness campaigns to advertise services to all types of victims (including men and LGBTQ + individuals), as well as integrating content around intersectionality and fetishization into trainings.

Cardiovascular disease continues to be the leading cause of death in women, surpassing the totals of the next seven causes of death. Of concern is whether women and older adults receive best-practice treatments, or whether clinical practice variation exists based on non-clinical factors when treating these groups. The purpose of this study is to examine the effects of age and gender on prescribing decisions for treatment of coronary heart disease, and to determine if adjustment for other patient, provider, and practice characteristics influences these decisions. Dependent variables include being on beta-blockers, ace inhibitors, and aspirin, as well as the combination of one or more of these cardiovascular medications. Between-group and within-group differences are examined. Data are obtained from the 2002 National Ambulatory Medical Care Survey. Overall prevalence estimates of being on a single medication or one or more of the medications are determined, and five models are tested in multivariate analysis to examine the impact of potential confounders on age and gender. A principal finding of the study is that women are consistently disadvantaged when compared to men. Women are less likely than men to be on aspirin (21% and 33% respectively, p-value = 0.01) and to be on one or more study medications (35% and 50% respectively, p-value = 0.00). In multivariate analysis, the odds of women being on study medications are 43% to 47% less than men for the same two outcomes noted above. Adults aged 65 and older are not disadvantaged when compared to younger adults, as there are no significant differences between groups for any of the outcomes. Confounders noted to be significant for one or more outcomes include black/African American race, two of four co-morbid diagnoses, and being seen by a cardiovascular specialist. The effect of race and ethnicity could not be fully assessed, however, due to small cell size. Policy initiatives related to health disparities should extend beyond racial and ethnic concerns to include gender. The Agency for Healthcare Research and Quality's focus on health disparities creates an opportunity for this broader focus, as gender is identified by the agency as a social identity that has potential for disparate healthcare treatment.

How important is the primary de- partment in the Sunday school! Is it not the most important of all V It em- braces the smallest children, up to the age of ten, eleven, or twelve years, ac- cording to physical or mental development.

The evils of intemperance can never be overestimated. The thought that generally comes to us at the first glance at the word \"Intemperance,\" is the indulgence in intoxicating drinks; but this is, by no means, the only way in which one can be intemperate, although this part itself is the source of a...

in memory of our dear mother who died on tho 9th of August, aged 72 yrs. and 4 mos.

When the children of Israel came forth from Egypt, as the covenant people of God, they became \"examples for us,\" and types of God's dealing with his covenant people in every age. They came to Mara first, and drank of its bitter waters. Life for us, too, will have its bitter fountains. But the waters are healed...

Endothelial progenitor cell (EPC) nomenclature remains ambiguous and there is a general lack of concordance in the stem cell field with many distinct cell subtypes continually grouped under the term \"EPC.\" It would be highly advantageous to agree on standards to confirm an endothelial progenitor phenotype and this should include detailed immunophenotyping, potency assays, and clear separation from hematopoietic angiogenic cells which are not endothelial progenitors. In this review, we seek to discourage the indiscriminate use of \"EPCs,\" and instead propose precise terminology based on defining cellular phenotype and function. Endothelial colony forming cells and myeloid angiogenic cells are examples of two distinct and well‐defined cell types that have been considered EPCs because they both promote vascular repair, albeit by completely different mechanisms of action. It is acknowledged that scientific nomenclature should be a dynamic process driven by technological and conceptual advances; ergo the ongoing \"EPC\" nomenclature ought not to be permanent and should become more precise in the light of strong scientific evidence. This is especially important as these cells become recognized for their role in vascular repair in health and disease and, in some cases, progress toward use in cell therapy. Stem Cells Translational Medicine 2017;6:1316–1320

Provision of safe drinking water in the United States is a great public health achievement. However, new waterborne disease challenges have emerged (e.g., aging infrastructure, chlorine-tolerant and biofilm-related pathogens, increased recreational water use). Comprehensive estimates of the health burden for all water exposure routes (ingestion, contact, inhalation) and sources (drinking, recreational, environmental) are needed. We estimated total illnesses, emergency department (ED) visits, hospitalizations, deaths, and direct healthcare costs for 17 waterborne infectious diseases. About 7.15 million waterborne illnesses occur annually (95% credible interval [CrI] 3.88 million-12.0 million), results in 601,000 ED visits (95% CrI 364,000-866,000), 118,000 hospitalizations (95% CrI 86,800-150,000), and 6,630 deaths (95% CrI 4,520-8,870) and incurring US $3.33 billion (95% CrI 1.37 billion-8.77 billion) in direct healthcare costs. Otitis externa and norovirus infection were the most common illnesses. Most hospitalizations and deaths were caused by biofilm-associated pathogens (nontuberculous mycobacteria, Pseudomonas, Legionella), costing US $2.39 billion annually.

Naegleria fowleri is a free-living ameba that causes primary amebic meningoencephalitis (PAM), a rare but usually fatal disease. We analyzed trends in recreational water exposures associated with PAM cases reported during 1978-2018 in the United States. Although PAM incidence remained stable, the geographic range of exposure locations expanded northward.